This invention concerns humanized antibodies specific for the lymphotoxin betareceptor (LT-.beta.-R), cell lines that produce these antibodies,immunochemicals made from the antibodies, and diagnostic methods that use theantibodies. The invention also relates to the use of the antibodies alone orin combination with chemotherapeutic agent(s) in therapeutic methods.
展开▼